Skip to search.
 TSX Up 0.14% TSX Ventures  0.00%
Streaming
Ticker Tape: On

Rigel Pharmaceuticals, Inc. (RIGL)

-NasdaqGS
3.22 Down 0.20(5.85%) 3:35PM EDT - Nasdaq Real Time Price
Add to Portfolio
Prev Close:3.42
Open:3.42
Bid:3.22 x 2200
Ask:3.23 x 500
1y Target Est:6.00
Beta:1.33
Earnings Date:May 5 - May 9 (Est.)
Day's Range:3.22 - 3.45
52wk Range:2.31 - 5.00
Volume:271,420
Avg Vol (3m):993,100
Market Cap:281.83M
P/E (ttm):N/A
EPS (ttm):-1.02
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Must Read

Comparison

Symbol% ChgMkt Cap
RIGLDown 5.85%281.83M
AMGNDown 5.16%85.42B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):41.86
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.06
Quarterly EPS Est (Mar-14) :-0.25
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Rigel Pharmaceuticals, Inc., a clinical-stage drug development company, discovers and develops novel, small-molecule drugs for the treatment of inflammatory and autoimmune diseases, as well as muscle disorders. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback